<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Triple negative breast cancer cell lines (MDA-MB-231, SUM 149) were used. The human breast cancer cell lines MDA-MB-231 (ATCC: HTB-26—Rockville, MD, USA) and SUM149 (SUM149PT—Asterand Bioscience Detroit, MI) were kindly provided by Dr. Elda Tagliabue (Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione Institute of Hospitalization and Scientific Care, National Cancer Institute, Milan, Italy) and were authenticated using the short tandem repeat profiling method in their Institute. The non-tumorigenic cell line 1-7HB2 (ECACC 10081201—Cancer Research Technology, London, UK) was kindly provided by Prof. Giulio Ghersi (STEBICEF Department, University of Palermo, Italy).</p>
